Interleukin-6 Is a Potential Biomarker for Severe Pandemic H1N1 Influenza A Infection
Stéphane G. Paquette(University Health Network), David J. Kelvin(Dalhousie University), Fang Yuan(University of British Columbia), David Andaluz(Junta de Castilla y León), Salvatore Rubino(University of Sassari), Ignacio Martín‐Loeches(St. James's Hospital), Jesús F. Bermejo-Martín(Hospital Clínico Universitario de Valladolid), Alberto J. León(University Health Network), Paola Sansonetti(Università Cattolica del Sacro Cuore), Jordi Rello(Centre Hospitalier Universitaire de Montpellier), Sigmund Krajden(St Joseph's Health Centre), Raquel Almansa(Universidad de Valladolid), Stephen S. H. Huang(University Health Network), Alyson A. Kelvin(Izaak Walton Killam Health Centre), Giovanni Delogu(Università Cattolica del Sacro Cuore), Zhen Zhao(Shantou University), Paula Ramírez(Hospital Universitari i Politècnic La Fe), Raúl Ortíz de Lejarazu(Instituto de Estudios de Ciencias de la Salud de Castilla y León), Barry B. Rubin(University of Toronto), Dat Tran(University of Toronto), Giovanni Fadda(Università Cattolica del Sacro Cuore), Lorenzo Socías(Hospital Son Llatzer), Jesús Blanco(Instituto de Salud Carlos III), Ana Loza, Derek C. K. Ng(McMaster University), David W. Banner(Roche (Switzerland)), Bianche Shum(St Joseph's Health Centre)
Cited by 143
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Fluorine in Medicinal Chemistry
|ChemBioChem|2004|1.5k
Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database
|CHEST Journal|2002|1.3k
Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit
|The Lancet Respiratory Medicine|2014|1.3k
Myocardial infarction accelerates atherosclerosis
|Nature|2012|1.1k